Axel Vater
Chief Scientific Officer Aptarion Biotech
Seminars
Wednesday 9th December 2026
Panel Discussion: Strategizing the Future of Complement Therapeutics Beyond Nephrology by Overcoming Biological, Translational & Development Bottlenecks to Treat a Plethora of Diseases
5:00 pm
- Discussing how emerging biology and novel mechanisms are expanding the therapeutic potential of complement beyond nephrology
- Exploring solutions to delivery, target engagement and sample collection challenges in difficult-to-access tissues
- Identifying the key factors for success in new indications, including target selection, patient stratification and translational validation
